Soonfast receives China patents for anti-HPV/HSV herbal
Tuesday, September 2, 2008
On August 30th Soonfast Pharmaceutical Science & Technology Co. Ltd. announced its patents of herbal anti-HPV medicine had been approved by the State Intellectual Property Office of China.
The product had shown an inhibitory effect on the growth of human papilloma virus (HPV) and herpes simplex virus (HSV). Experiments have also proved that the herbal medicine is effective against multiple HPV types including 6, 11, 16, 18 and 33.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.